Acceleration of Bone Fracture Healing through the Use of Natural Bovine Hydroxyapatite Implant on Bone Defect Animal Model

Junaidi Khotib, Cantika SC Lasandara, Samirah Samirah, Aniek S Budiatin

= http://dx.doi.org/10.20473/fmi.v55i3.15495
Abstract views = 1278 times | downloads = 2050 times

Abstract


Bone is an important organ for supports the body that stores reserve of calcium, phosphorus, and other minerals. In fracture conditions where bleeding, soft tissue edema, nerve damage, and blood vessels around the bone damage happen, they can cause the mobilization of these minerals in the surrounding tissue. One of the efforts made in the treatment of these fractures is reconnection, in which it works by filling of bone defect with a matrix and administration of anti-infection. Biomaterial filling in defective bone is thought to accelerate the healing process of bone fracture and prevent osteomyelitis. For this reason, this study evaluates the acceleration of bone fracture healing using natural hydroxyapatite (NHA) bone filler in rabbits with bone defect model. Fracture modeling was performed by surgical technique and drilling of bones with a 4.2 mm diameter to form a defect in the rabbit femur. Bone implant contained bovine hydroxyapatite-gelatin-glutaraldehyde (BHA implant) or bovine hydroxyapatite-gelatin-glutaraldehyde-gentamicin (BHA-GEN implant) that was inserted in bone defects. 27 rabbits were divided into 3 groups: the control group who had bone defect, the bone defect group was given BHA implant and the bone defect group was given BHA-GEN implant. Observation of osteoclast, osteoblast, osteocyte, BALP level, and bone morphological integrity was carried out on the 14th, 28th, and 42nd days after surgery. Histological observation of rabbit femur showed a significant difference on the number of osteoclast, osteoblast and osteocyte in all three groups. The BALP level also showed a significant difference in the group given the natural BHA bone implant compared to the control group on day 14 (p = 0.0361). Based on the result of the X-ray, there was also a better integration of rabbit femur bone in groups with the use of BHA or BHA-GEN bone implant. Thus, it can be concluded that the use of a natural BHA implant can accelerate the process of bone repair in the fracture of rabbit femur. In addition, BHA implants were compatible as a matrix for supporting the bone cell growth.

Keywords


Bone remodeling; fracture; natural bovine hydroxyapatite; bone alkaline phosphatase

Full Text:

PDF

References


Askarzadeh K, People F, Moztarzadeh F (2005). Fabrication and characterization of a porous compo-site implant based on gelatin and hydroxyapatite for bone tissue engineering. Iranian Polymer Journal 14, 511-520

Azami M, Tavakol S, Samadikuchaksaraei A, Hashjin SM, Baheiraei N, Kamali M, Nourani MR (2012). A porous hydroxyapatite/gelatin nanocomposite implant for bone tissue repair: In vitro and in vivo evaluation. Journal of Biomaterial Science 23, 2353-2368

Boanini E, Torricelli P, Gazzano M, Giardino R, Bigi A (2008). Alendronate - hydroxyapatite nanocomposites and their interaction with osteoclasts and osteoblast - like cells. J. Biomaterials 29, 790-796

Brunner & Suddarth (1997). Brunner and Suddarth’s Journal of Medical-Surgical Nursing . 7th Ed. 6-15.

Budiatin Aniek Setiya, et al (2013). Gentamicin release from bovin-hydroxy-apatite-gelatin implant as a drug and bone filling delivery system. Indonesian Journal of Pharmacy and Pharmaceutical Sciences 1, 10-11

Budiatin AS, Zainuddin M, Khotib J (2014). Biocompatable composite as gentamicin delivery system for osteomyelitis and bone regeneration. International Journal of Pharmacy and Pharmaceutical Sciences 6, 223-226

Capra P, Dorati R, Colonna C, Giovanna B, Pavanetto, F, Genta I, Conti B (2011). A preliminary study on the morphological and release properties of hydroxyapa-tite-alendronate composite materials. Journal of Microencapsulation 28, 395-405

Cattalini JP, Boccaccini AR, Habil Dr.-Ing, Lucangioli S, Mourino V (2012). Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Engineering Part B 18, 5-8

Chang J, Lin K (2015). Structure and properties of hydroxyapatite for biomedical applications. Hap for Biomedical Applications, 3-19

Chao SC, Wang MJ, Pai NS, Yen SK (2015). Preparation and characterization of gelatin-hydroxyapatite composite microspheres for hard tissue repair. Materials Science and Engineering C 57, 113-122

Chen G, Deng C, Li YP (2012). TGF-β and BMP signaling in osteoblast differentiation and bone formation. International Journal of Biological Sciences 8, 272-288

Cottrell JA, Vales FM, Schachter D, Wadsworth S, Gundlapalli R, Kapadia R, O'Connor JP (2010). Osteogenic activity of locally applied small molecule drugs in a rat femur defect model. Journal of Biomedicine and Biotechnology 597641, 1-2

Einhorn TA (2010). Can an anti-fracture agent heal fractures?. Clinical Cases in Minerals and Bone Metabolism 6, 251-253

Einhorn TA, Gerstenfeld LC (2014). Fracture healing: Mechanism and interventions. Nature Reviews Rheumatology, 355-337

Ellis EG, Kathleen B (2007). The role of alkaline phosphatase in mineralization. Curr Opin Orthop 18, 444-448

Ferdiansyah, Rushadi D, Rantam FA, Aulani'am (2010). Regeneration of massive bone defect with bovine hydroxyapatite as mesenchymal stem cells' implants 13, 179-195

Fischer AH, Jacobson KA, Rose J, Zeller R (2008). Hematoxylin and eosin staining of tissue and cell sections. Cold Spring Harbor Protocols 3, 4986-4988

Goes P, Melo MI, Dutra SC, Lima SPA, Lima V (2012). Effect of alendronate on bone - specific alkaline phosphatase on periodontal bone loss in rats. Archives of Oral Biology 57, 1537-1274

Greenblatt MB, Tsi JN, Wein, MN (2017). Bone turnover markers in the diagnosis and monitoring of metabolic bone disease. Clinical Chemistry 63, 464-474

Guyton AC, Hall JE (2007). Medical physiology textbook. 9th Ed. Jakarta, EGC, p 6-7

Hikmawati D, Maulida HN, Putra AP, Budiatin AS and Syahrom A (2019). Synthesis and characterization of nanohydroxyapatite-gelatin composite with streptomy-cin as antituberculosis injectable bone substitute. International Journal of Biomaterials 2019

Kalfas IH (2001). Principles of bone healing. Neurosurg Focus 10, 7-10

Kim, HW, Knowles, JC, Kim HE (2004). Hydroxyapatite and gelatin composite foams processed via novel freeze-drying and crosslinking for use as temporary hard tissue implants. Journal of Biomedical Materials Research - Part A 72, 136-145

Kusrini E, Sontang M (2012). Characterization of X-ray diffraction and electron spin resonance: Effects of sintering time and temperature on bovine hydroxyapatite. Rad Physical and Chem, 118-125

Marsell R, Einhorn TA (2011). The biology of fracture healing. Injury 42, 551-555

Maulida HN, Hikmawati D, Budiatin AS (2015). Injectable bone substitute paste based on hydroxyapatite, gelatin and streptomycin for spinal tuberculosis. The Spine Journal 4, 4-7

Narbat KM, Orang F, Hashtjin SM, Goudarzi A (2006). Fabrication of porous hydroxyapatite-gelatin composite implans for bone tissue engineering. Iranian Biomed J. 10, 215-223

Ning B, Zhao Y, Buza III JA, Li W, Wang W, Jia T (2017). Surgically-induced mouse models in the study of bone regeneration: Current models and future directions. Molecular Medicine Reports 15, 1017-1023

Pagani F, Francucci CM, Moro L (2005). Markers of bone turnover: Biochemical and clinical perspectives J Endocrinol Invest 28, 8-13

Raggatt LJ, Partridge NC (2010). Cellular and molecular mechanism of bone remodeling. Journal of Biological Chemistry 285, 25103-25108

Ramirez-Fernandez MP, Calvo-Guirado JL, Delgado-Ruiz RA, Mate-Sanchez del Val JE, Gomez-Moreno G, Guardia J (2011). Experimental model of bone response to xenografts of bovine origin (Endone®): a radiological and histomorphometric study. Clin.Oral Impl.Res 22, 727-734

Schlickewei WC, Laaff G, Andresen A, Klatte OT, Rueger Mj, Ruesing J, Epple M, Lehmann W (2015). Bone augmentation using a new injectable bone graft substitute by combining calcium phosphate and bisphosphonate as composite - an animal model. Journal of Orthopedic Surgery and Research 10, 116

Seibel MJ (2000). Molecular markers of bone turnover: biochemical, technical and analytical aspects. International Osteoporosis Foundation and National Osteoporosis Foundation 6, S18-29

Sihombing D, Nursiswati, Prawesti A (2012). Overview of foot care and sensory sensation of feet in patients with type 2 diabetes mellitus in the dm polyclinic hospital

Silva RF, Sasso GRD, Cerri ES, Simoes MJ, Cerri PS (2015). Review article. Biology of bone tissue: structure, function, and factors that influence bone cells. BioMed Research International 2015, 1-17

Sousa CP, Dias IR, Pena ML, Camassa JA, Lourenco PJ, Judas FM, Gomes ME, Reis RL (2015). Bone turnover markers for early detection of fracture healing disturbances. Anais da Academia Brasileira de Ciencias 87, 1049-1061


Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Junaidi Khotib, Cantika SC Lasandara, Samirah Samirah, Aniek S Budiatin

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Indexed By

View My Stats

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.